Save your place

Sign in to WhoBought

Please try again later.

Protara Therapeutics, Inc. (TARA) institutional ownership

Latest close $4.34 May 19, 2026
Market cap$123M 52-week range SectorHealthcare
Funds holding · Q1 2026
118
reported TARA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net bought $34M
75 buyers · 43 sellers

Protara Therapeutics, Inc. (TARA) price and institutional activity

Dates

Q1 2026

$78M bought by 75 investors
Millennium Management LLC$12MAigh Capital Management LLC$9.6M +73 more
$43M sold by 43 investors
Driehaus Capital Management LLC-$7.5MAdage Capital Partners Gp, L.L.C.-$6.2M +41 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Protara Therapeutics, Inc. (TARA) institutional activity · 118

Investor Type Est. change Change Δ Own Date
Millennium Management LLC · Added +$12M
Change +2.1M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +$12M +2.1M Q1 2026
Aigh Capital Management LLC · New +$9.6M
Change +1.6M Date Q1 2026
Aigh Capital Management LLC New· Q1 2026 +$9.6M +1.6M Q1 2026
Driehaus Capital Management LLC · Exited −$7.5M
Change −1.3M Δ Own −100.0% Date Q1 2026
Driehaus Capital Management LLC Exited· Q1 2026 −$7.5M −1.3M −100.0% Q1 2026
Point72 Asset Management, L.P. · Added +$6.7M
Change +1.1M Δ Own +4001.2% Date Q1 2026
Point72 Asset Management, L.P. Added· Q1 2026 +$6.7M +1.1M +4001.2% Q1 2026
Adage Capital Partners Gp, L.L.C. · Exited −$6.2M
Change −1.0M Δ Own −100.0% Date Q1 2026
Adage Capital Partners Gp, L.L.C. Exited· Q1 2026 −$6.2M −1.0M −100.0% Q1 2026
Patient Square Capital LP · New +$6.1M
Change +1.0M Date Q1 2026
Patient Square Capital LP New· Q1 2026 +$6.1M +1.0M Q1 2026
BlackRock · Added +$5.8M
Change +986K Date Q1 2026
BlackRock Added· Q1 2026 +$5.8M +986K Q1 2026
Catalio Capital Management, LP · Reduced −$5.1M
Change −866K Date Q1 2026
Catalio Capital Management, LP Reduced· Q1 2026 −$5.1M −866K Q1 2026
J. Goldman & Co LP · New +$5.1M
Change +856K Date Q1 2026
J. Goldman & Co LP New· Q1 2026 +$5.1M +856K Q1 2026
Maven Securities Ltd · Exited −$4.5M
Change −755K Δ Own −100.0% Date Q1 2026
Maven Securities Ltd Exited· Q1 2026 −$4.5M −755K −100.0% Q1 2026
Sphera Funds Management Ltd. · Exited −$3.8M
Change −650K Δ Own −100.0% Date Q1 2026
Sphera Funds Management Ltd. Exited· Q1 2026 −$3.8M −650K −100.0% Q1 2026
Marshall Wace, LLP · Reduced −$3.2M
Change −534K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −$3.2M −534K Q1 2026
Vanguard · Added +$3.0M
Change +501K Date Q1 2026
Vanguard Added· Q1 2026 +$3.0M +501K Q1 2026
Integral Health Asset Management, LLC · Reduced −$3.0M
Change −500K Date Q1 2026
Integral Health Asset Management, LLC Reduced· Q1 2026 −$3.0M −500K Q1 2026
State Street · Added +$2.6M
Change +434K Date Q1 2026
State Street Added· Q1 2026 +$2.6M +434K Q1 2026
Data through Q1 2026 · filed May 21, 2026
15 of 118

Famous investor activity in Protara Therapeutics, Inc. (TARA)

Protara Therapeutics, Inc. (TARA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Shefferman Jesse · Director 4 operations -30K
Owned 692K ΔOwn −4.2% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Shefferman Jesse Director 4 operations -30K 692K −4.2% Jun 30, 2026 Jul 1, 2026
Shefferman Jesse · Director Sell −$882K
Price $4.09 Qty −216K Owned 722K ΔOwn −23.0% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Shefferman Jesse Director Sell $4.09 −216K −$882K 722K −23.0% Jun 29, 2026 Jul 1, 2026
Shefferman Jesse · Director 2 operations 0
Price $1.91 Owned 141K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Shefferman Jesse Director 2 operations $1.91 0 141K Jun 29, 2026 Jul 1, 2026
Levy Richard S. · Director Grant (A) 31K
Owned 31K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Levy Richard S. Director Grant (A) 31K 31K Jun 15, 2026 Jun 16, 2026
Solomon Michael Edward · Director Grant (A) 31K
Owned 31K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Solomon Michael Edward Director Grant (A) 31K 31K Jun 15, 2026 Jun 16, 2026
Smith Cynthia · Director Grant (A) 31K
Owned 31K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Smith Cynthia Director Grant (A) 31K 31K Jun 15, 2026 Jun 16, 2026
Sargen Gregory · Director Grant (A) 31K
Owned 31K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Sargen Gregory Director Grant (A) 31K 31K Jun 15, 2026 Jun 16, 2026
Huang Jane · Director Grant (A) 31K
Owned 31K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Huang Jane Director Grant (A) 31K 31K Jun 15, 2026 Jun 16, 2026
Garceau Roger · Director Grant (A) 31K
Owned 31K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Garceau Roger Director Grant (A) 31K 31K Jun 15, 2026 Jun 16, 2026
Flannelly Barry P. · Director Grant (A) 31K
Owned 31K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Flannelly Barry P. Director Grant (A) 31K 31K Jun 15, 2026 Jun 16, 2026
Beshar Luke M. · Director Grant (A) 31K
Owned 31K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Beshar Luke M. Director Grant (A) 31K 31K Jun 15, 2026 Jun 16, 2026
Conkling William · Officer Tax withholding or exercise payment (F) -$26K
Price $4.34 Qty -6K Owned 70K Trade date Jun 2, 2026 Filed date Jun 3, 2026
Conkling William Officer Tax withholding or exercise payment (F) $4.34 -6K -$26K 70K Jun 2, 2026 Jun 3, 2026
Zummo Jacqueline · Officer Sell −$6K
Price $5.40 Qty −1K Owned 95K Trade date Apr 8, 2026 Filed date Apr 9, 2026
Zummo Jacqueline Officer Sell $5.40 −1K −$6K 95K Apr 8, 2026 Apr 9, 2026
Zummo Jacqueline · Officer Sell −$119K
Price $5.26 Qty −23K Owned 96K Trade date Apr 1, 2026 Filed date Apr 2, 2026
Zummo Jacqueline Officer Sell $5.26 −23K −$119K 96K Apr 1, 2026 Apr 2, 2026
Fry Hannah · Officer Tax withholding or exercise payment (F) -$10K
Price $6.67 Qty -1K Owned 43K Trade date Jan 26, 2026 Filed date Jan 27, 2026
Fry Hannah Officer Tax withholding or exercise payment (F) $6.67 -1K -$10K 43K Jan 26, 2026 Jan 27, 2026
15 of 28
15 of 28 Sign in to continue to older insider transactions.

Protara Therapeutics, Inc. (TARA) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Janus Henderson Group PLC 5.2M
% of shares outstanding 9.6% Filing date May 15, 2026
Janus Henderson Group PLC 5.2M 9.6% May 15, 2026
Adage Capital Management, L.P. 2.2M
% of shares outstanding 6.6% Filing date Feb 12, 2025
Adage Capital Management, L.P. 2.2M 6.6% Feb 12, 2025
Blackrock, Inc. 3.4M
% of shares outstanding 6.3% Filing date Apr 27, 2026
Blackrock, Inc. 3.4M 6.3% Apr 27, 2026
Velan Capital Investment Management LP 2.1M
% of shares outstanding 6.0% Filing date Dec 17, 2024
Velan Capital Investment Management LP 2.1M 6.0% Dec 17, 2024
Integrated Core Strategies (us) LLC 2.9M
% of shares outstanding 5.1% Filing date Jul 7, 2026
Integrated Core Strategies (us) LLC 2.9M 5.1% Jul 7, 2026
Ra Capital Management, L.P. 2.0M
% of shares outstanding 4.9% Filing date Aug 14, 2025
Ra Capital Management, L.P. 2.0M 4.9% Aug 14, 2025
Opaleye Management, Inc. 1.7M
% of shares outstanding 4.7% Filing date Apr 28, 2025
Opaleye Management, Inc. 1.7M 4.7% Apr 28, 2025
Citadel Advisors LLC 1.6M
% of shares outstanding 4.6% Filing date Feb 14, 2025
Citadel Advisors LLC 1.6M 4.6% Feb 14, 2025
8 of 9

Protara Therapeutics, Inc. (TARA) ownership FAQ

Who owns TARA?

118 reporting institutions disclosed TARA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.